Skip to main content
TRELLUS HEALTH PLC logo

TRELLUS HEALTH PLC — Investor Relations & Filings

Ticker · TRLS ISIN · GB00BNNFM402 LEI · 2138002FHWJSR8YKP295 IL Human health and social work activities
Open in API
Filings indexed 120 across all filing types
Latest filing 2026-05-08 Capital/Financing Update
Country GB United Kingdom
Listing IL TRLS

About TRELLUS HEALTH PLC

https://trellushealth.com/

Trellus Health PLC is a digital health company that provides solutions for managing complex chronic conditions by addressing the intersection of physical and mental health. The company's core offering is Trellus Elevate®, a clinically proven, resilience-focused program. This platform combines human-led, one-on-one virtual support from a specialized team of coaches, dietitians, and educators with personalized digital tools for symptom management and progress tracking. The program aims to empower individuals to proactively manage their health, improve adherence to treatment plans, and enhance their quality of life. Trellus Health's solutions are designed to reduce healthcare costs for its partners, which include health plans, employers, providers, health systems, and pharmaceutical companies.

Recent filings

Filing Released Lang Actions
Update on Funding & Suspension of Trading
Capital/Financing Update Classification · 95% confidence The document is an announcement from Trellus Health plc dated 08 May 2026. It provides an update on the company's funding situation, including cash burn, runway extension, engagement of corporate restructuring advisers, and suspension of trading on AIM. The text does not contain detailed financial statements or comprehensive financial data but rather discusses funding status, strategic options, and trading suspension. It is a regulatory announcement about funding and trading suspension rather than a full financial report or earnings release. The document is about funding update and trading suspension, which fits best under Capital/Financing Update (CAP). The length (6474 characters) and content confirm it is not a brief notice or a report publication announcement. Therefore, the classification is CAP with high confidence.
2026-05-08 English
Issue of Equity - Conversion of Loan Notes
Share Issue/Capital Change Classification · 90% confidence The document is an RNS announcement detailing the issuance of 59,070,234 new ordinary shares following conversion of loan notes and the corresponding update of total voting rights. This is a direct announcement of a new share issue/capital change. Therefore, it falls under the Share Issue/Capital Change category (SHA).
2026-04-28 English
Pfizer Licensing Agreement Renewal
Regulatory Filings Classification · 75% confidence The document is a press release via the London Stock Exchange RNS service announcing a commercial licensing agreement renewal between Trellus Health and Pfizer. It does not present financial results, dividend details, management changes, regulatory stress tests, or fundraising. Instead, it is a general regulatory announcement published through RNS that doesn’t fit any of the more specific categories. Therefore it falls under the fallback category for miscellaneous regulatory announcements.
2026-04-13 English
Issue of Equity - Conversion of Loan Notes
Share Issue/Capital Change Classification · 95% confidence The document is an RNS announcement from Trellus Health plc regarding the conversion of loan notes into new ordinary shares, application for admission, and total voting rights. It is an announcement of new share issuance / capital change. According to filing definitions, this is a Share Issue/Capital Change (SHA).
2026-04-08 English
Funding Update
Capital/Financing Update Classification · 92% confidence The document is an RNS announcement titled "Funding Update" and details the company entering into a US$50,000 unsecured loan agreement (a related party transaction) to extend its cash runway, with interest and maturity terms described. This is a classic capital/financing update, providing an update on the company’s fundraising and financing activities. It is not an earnings release, share issue notice, or report publication announcement.
2026-04-02 English
MSA Signed and Funding Update
Capital/Financing Update Classification · 85% confidence The document is an RNS announcement containing inside information under UK MAR. It is not an earnings release or a full financial report but rather provides a business update (signing of an MSA) and, importantly, details on the company’s cash burn, cash runway, potential director loans, and status of its convertible facility. These are updates on the company’s financing and funding strategy rather than an operational report or statutory filing. Therefore it best fits the Capital/Financing Update category.
2026-03-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.